Sale!

ADAMTS-13 FRET Substrate

Original price was: $146.00.Current price is: $36.50.

SKU: PW14836851853 Category:

Description

ADAMTS-13 FRET Substrate

Catalog number: B2011287
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.1 mg
Molecular Weight or Concentration: 8314.9 g/mol
Supplied as: Lyophilized
Applications: molecular tool for various biochemical applications
Storage: -20 C
Keywords: FRETS-VWF73
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Levi M, Scully M, Singer M. The role of ADAMTS-13 in the coagulopathy of sepsis J Thromb Haemost. 2018 Apr;16(4):646-651.
  • Boender J, Nederlof A, Meijer K, Mauser-Bunschoten EP, Cnossen MH, Fijnvandraat K, van der Bom JG, de Meris J, Laros-van Gorkom BAP, van Galen KPM, Eikenboom J, de Maat MPM, Leebeek FWG; WiN Study Group. ADAMTS-13 and bleeding phenotype in von Willebrand disease Res Pract Thromb Haemost. 2020 Oct 31;4(8):1331-1339.
  • South K, Lane DA. ADAMTS-13 and von Willebrand factor: a dynamic duo J Thromb Haemost. 2018 Jan;16(1):6-18.
  • Veyradier A, Girma JP. Assays of ADAMTS-13 activity Semin Hematol. 2004 Jan;41(1):41-7.
  • South K, Freitas MO, Lane DA. Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity J Thromb Haemost. 2016 Oct;14(10):2011-2022.
  • Zhou Z, Nguyen TC, Guchhait P, Dong JF. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura Semin Thromb Hemost. 2010 Feb;36(1):71-81.
  • Zwicker JI, Muia J, Dolatshahi L, Westfield LA, Nieters P, Rodrigues A, Hamdan A, Antun AG, Metjian A, Sadler JE; ART Investigators. Adjuvant low-dose rituximab and plasma exchange for acquired TTP Blood. 2019 Sep 26;134(13):1106-1109.
  • Halkidis K, Siegel DL, Zheng XL. A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura J Thromb Haemost. 2021 Aug;19(8):1888-1895.
  • Pekcan MK, Sarkaya E, Tokmak A, Alk M, Alkan A, zakit G, Erel . ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion Kaohsiung J Med Sci. 2017 Jan;33(1):30-35.